AR BROWN CO., LTD.

Co-promotes SSK Biosciences and Vannsh Lifesciences at CPHI under the ARBROWN banner. SSK offers agile CDMO support, process development, GMP manufacturing and analytical services, while Vannsh focuses on high-potency oncology APIs such as Ibrutinib, Osimertinib, Venetoclax, Abemaciclib, Dabrafenib and Ribociclib, backed by global filings. ARBROWN connects trusted partners across Asia, Europe and beyond.